Judge Lets Gout Drug Antitrust Suit Move Forward
An antitrust suit accusing Takeda Pharmaceuticals of striking anti-competitive deals to beat back generic competition on its anti-gout drug Colcrys is teed up for trial after a Pennsylvania federal judge refused...To view the full article, register now.
Already a subscriber? Click here to view full article